HEADER IMMUNE SYSTEM 22-MAY-19 6RST TITLE TBK1 IN COMPLEX WITH INHIBITOR COMPOUND 24 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE TBK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NF-KAPPA-B-ACTIVATING KINASE,T2K,TANK-BINDING KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TBK1, NAK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, INNATE IMMUNITY, SMALL MOLECULE INHIBITOR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.PANNE,R.C.HILLIG,S.RENGACHARI REVDAT 5 15-MAY-24 6RST 1 REMARK REVDAT 4 04-MAR-20 6RST 1 REMARK REVDAT 3 05-FEB-20 6RST 1 JRNL REVDAT 2 22-JAN-20 6RST 1 JRNL REVDAT 1 01-JAN-20 6RST 0 JRNL AUTH J.LEFRANC,V.K.SCHULZE,R.C.HILLIG,H.BRIEM,F.PRINZ,A.MENGEL, JRNL AUTH 2 T.HEINRICH,J.BALINT,S.RENGACHARI,H.IRLBACHER,D.STOCKIGT, JRNL AUTH 3 U.BOMER,B.BADER,S.N.GRADL,C.F.NISING,F.VON NUSSBAUM, JRNL AUTH 4 D.MUMBERG,D.PANNE,A.M.WENGNER JRNL TITL DISCOVERY OF BAY-985, A HIGHLY SELECTIVE TBK1/IKK EPSILON JRNL TITL 2 INHIBITOR. JRNL REF J.MED.CHEM. V. 63 601 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31859507 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01460 REMARK 2 REMARK 2 RESOLUTION. 3.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 14377 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.303 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1366 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.6400 - 7.0900 0.99 2591 134 0.1915 0.2782 REMARK 3 2 7.0900 - 5.6300 1.00 2590 136 0.2581 0.2809 REMARK 3 3 5.6300 - 4.9200 0.99 2556 134 0.2352 0.2880 REMARK 3 4 4.9200 - 4.4700 1.00 2632 142 0.2307 0.2767 REMARK 3 5 4.4700 - 4.1500 1.00 2553 136 0.2547 0.3416 REMARK 3 6 4.1500 - 3.9100 1.00 2642 141 0.2638 0.2998 REMARK 3 7 3.9100 - 3.7100 0.99 2561 136 0.2944 0.3487 REMARK 3 8 3.7100 - 3.5500 0.98 2587 136 0.3374 0.3844 REMARK 3 9 3.5500 - 3.4100 1.00 2571 133 0.3587 0.3527 REMARK 3 10 3.4100 - 3.2900 0.98 2555 138 0.3940 0.4028 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.641 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.995 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 118.8 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 127.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5215 REMARK 3 ANGLE : 0.921 7047 REMARK 3 CHIRALITY : 0.048 782 REMARK 3 PLANARITY : 0.005 894 REMARK 3 DIHEDRAL : 6.175 3134 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6RST COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1292102423. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14377 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.290 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.49 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES PH 7.5 AND 5-8% PEG 8000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.13000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.06500 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 29.06500 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 58.13000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 174.39000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -5 REMARK 465 SER A -4 REMARK 465 GLY A -3 REMARK 465 GLU A 165 REMARK 465 ASP A 166 REMARK 465 ASP A 167 REMARK 465 GLU A 168 REMARK 465 GLN A 169 REMARK 465 PHE A 170 REMARK 465 VAL A 171 REMARK 465 SER A 172 REMARK 465 LEU A 173 REMARK 465 TYR A 174 REMARK 465 ARG A 187 REMARK 465 ALA A 188 REMARK 465 VAL A 189 REMARK 465 LEU A 190 REMARK 465 ARG A 191 REMARK 465 LYS A 192 REMARK 465 ASP A 193 REMARK 465 HIS A 194 REMARK 465 GLN A 195 REMARK 465 LYS A 196 REMARK 465 LYS A 197 REMARK 465 TYR A 198 REMARK 465 GLU A 483 REMARK 465 LYS A 484 REMARK 465 LEU A 485 REMARK 465 MET A 486 REMARK 465 LYS A 487 REMARK 465 ILE A 488 REMARK 465 ASN A 489 REMARK 465 LEU A 490 REMARK 465 GLU A 491 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A -2 CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HG SER A 315 HE22 GLN A 318 1.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLY A 18 HD22 ASN A 42 5677 1.31 REMARK 500 HG SER A 3 OE2 GLU A 656 5667 1.46 REMARK 500 OE2 GLU A 355 HH11 ARG A 444 4557 1.55 REMARK 500 OE2 GLU A 355 HE1 TRP A 445 4557 1.57 REMARK 500 OH TYR A 577 O LEU A 654 2664 1.79 REMARK 500 OG SER A 3 OE2 GLU A 656 5667 2.10 REMARK 500 O GLY A 18 ND2 ASN A 42 5677 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 61 69.89 -104.72 REMARK 500 ASP A 135 29.13 -152.93 REMARK 500 PRO A 227 44.70 -84.96 REMARK 500 SER A 243 -126.17 41.24 REMARK 500 SER A 268 43.79 -83.73 REMARK 500 ARG A 573 -41.05 69.83 REMARK 500 GLU A 604 -59.02 -130.86 REMARK 500 TYR A 650 -73.66 -92.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KHQ A 701 DBREF 6RST A 2 657 UNP Q9UHD2 TBK1_HUMAN 2 657 SEQADV 6RST GLY A -5 UNP Q9UHD2 EXPRESSION TAG SEQADV 6RST SER A -4 UNP Q9UHD2 EXPRESSION TAG SEQADV 6RST GLY A -3 UNP Q9UHD2 EXPRESSION TAG SEQADV 6RST SER A -2 UNP Q9UHD2 EXPRESSION TAG SEQADV 6RST ALA A -1 UNP Q9UHD2 EXPRESSION TAG SEQADV 6RST MET A 0 UNP Q9UHD2 EXPRESSION TAG SEQADV 6RST GLY A 1 UNP Q9UHD2 EXPRESSION TAG SEQRES 1 A 663 GLY SER GLY SER ALA MET GLY GLN SER THR SER ASN HIS SEQRES 2 A 663 LEU TRP LEU LEU SER ASP ILE LEU GLY GLN GLY ALA THR SEQRES 3 A 663 ALA ASN VAL PHE ARG GLY ARG HIS LYS LYS THR GLY ASP SEQRES 4 A 663 LEU PHE ALA ILE LYS VAL PHE ASN ASN ILE SER PHE LEU SEQRES 5 A 663 ARG PRO VAL ASP VAL GLN MET ARG GLU PHE GLU VAL LEU SEQRES 6 A 663 LYS LYS LEU ASN HIS LYS ASN ILE VAL LYS LEU PHE ALA SEQRES 7 A 663 ILE GLU GLU GLU THR THR THR ARG HIS LYS VAL LEU ILE SEQRES 8 A 663 MET GLU PHE CYS PRO CYS GLY SER LEU TYR THR VAL LEU SEQRES 9 A 663 GLU GLU PRO SER ASN ALA TYR GLY LEU PRO GLU SER GLU SEQRES 10 A 663 PHE LEU ILE VAL LEU ARG ASP VAL VAL GLY GLY MET ASN SEQRES 11 A 663 HIS LEU ARG GLU ASN GLY ILE VAL HIS ARG ASP ILE LYS SEQRES 12 A 663 PRO GLY ASN ILE MET ARG VAL ILE GLY GLU ASP GLY GLN SEQRES 13 A 663 SER VAL TYR LYS LEU THR ASP PHE GLY ALA ALA ARG GLU SEQRES 14 A 663 LEU GLU ASP ASP GLU GLN PHE VAL SER LEU TYR GLY THR SEQRES 15 A 663 GLU GLU TYR LEU HIS PRO ASP MET TYR GLU ARG ALA VAL SEQRES 16 A 663 LEU ARG LYS ASP HIS GLN LYS LYS TYR GLY ALA THR VAL SEQRES 17 A 663 ASP LEU TRP SER ILE GLY VAL THR PHE TYR HIS ALA ALA SEQRES 18 A 663 THR GLY SER LEU PRO PHE ARG PRO PHE GLU GLY PRO ARG SEQRES 19 A 663 ARG ASN LYS GLU VAL MET TYR LYS ILE ILE THR GLY LYS SEQRES 20 A 663 PRO SER GLY ALA ILE SER GLY VAL GLN LYS ALA GLU ASN SEQRES 21 A 663 GLY PRO ILE ASP TRP SER GLY ASP MET PRO VAL SER CYS SEQRES 22 A 663 SER LEU SER ARG GLY LEU GLN VAL LEU LEU THR PRO VAL SEQRES 23 A 663 LEU ALA ASN ILE LEU GLU ALA ASP GLN GLU LYS CYS TRP SEQRES 24 A 663 GLY PHE ASP GLN PHE PHE ALA GLU THR SER ASP ILE LEU SEQRES 25 A 663 HIS ARG MET VAL ILE HIS VAL PHE SER LEU GLN GLN MET SEQRES 26 A 663 THR ALA HIS LYS ILE TYR ILE HIS SER TYR ASN THR ALA SEQRES 27 A 663 THR ILE PHE HIS GLU LEU VAL TYR LYS GLN THR LYS ILE SEQRES 28 A 663 ILE SER SER ASN GLN GLU LEU ILE TYR GLU GLY ARG ARG SEQRES 29 A 663 LEU VAL LEU GLU PRO GLY ARG LEU ALA GLN HIS PHE PRO SEQRES 30 A 663 LYS THR THR GLU GLU ASN PRO ILE PHE VAL VAL SER ARG SEQRES 31 A 663 GLU PRO LEU ASN THR ILE GLY LEU ILE TYR GLU LYS ILE SEQRES 32 A 663 SER LEU PRO LYS VAL HIS PRO ARG TYR ASP LEU ASP GLY SEQRES 33 A 663 ASP ALA SER MET ALA LYS ALA ILE THR GLY VAL VAL CYS SEQRES 34 A 663 TYR ALA CYS ARG ILE ALA SER THR LEU LEU LEU TYR GLN SEQRES 35 A 663 GLU LEU MET ARG LYS GLY ILE ARG TRP LEU ILE GLU LEU SEQRES 36 A 663 ILE LYS ASP ASP TYR ASN GLU THR VAL HIS LYS LYS THR SEQRES 37 A 663 GLU VAL VAL ILE THR LEU ASP PHE CYS ILE ARG ASN ILE SEQRES 38 A 663 GLU LYS THR VAL LYS VAL TYR GLU LYS LEU MET LYS ILE SEQRES 39 A 663 ASN LEU GLU ALA ALA GLU LEU GLY GLU ILE SER ASP ILE SEQRES 40 A 663 HIS THR LYS LEU LEU ARG LEU SER SER SER GLN GLY THR SEQRES 41 A 663 ILE GLU THR SER LEU GLN ASP ILE ASP SER ARG LEU SER SEQRES 42 A 663 PRO GLY GLY SER LEU ALA ASP ALA TRP ALA HIS GLN GLU SEQRES 43 A 663 GLY THR HIS PRO LYS ASP ARG ASN VAL GLU LYS LEU GLN SEQRES 44 A 663 VAL LEU LEU ASN CYS MET THR GLU ILE TYR TYR GLN PHE SEQRES 45 A 663 LYS LYS ASP LYS ALA GLU ARG ARG LEU ALA TYR ASN GLU SEQRES 46 A 663 GLU GLN ILE HIS LYS PHE ASP LYS GLN LYS LEU TYR TYR SEQRES 47 A 663 HIS ALA THR LYS ALA MET THR HIS PHE THR ASP GLU CYS SEQRES 48 A 663 VAL LYS LYS TYR GLU ALA PHE LEU ASN LYS SER GLU GLU SEQRES 49 A 663 TRP ILE ARG LYS MET LEU HIS LEU ARG LYS GLN LEU LEU SEQRES 50 A 663 SER LEU THR ASN GLN CYS PHE ASP ILE GLU GLU GLU VAL SEQRES 51 A 663 SER LYS TYR GLN GLU TYR THR ASN GLU LEU GLN GLU THR HET KHQ A 701 40 HETNAM KHQ 1-[4-[(1~{R})-1-[2-[[5-[1-(CYCLOPROPYLMETHYL)PYRAZOL-4- HETNAM 2 KHQ YL]-1~{H}-BENZIMIDAZOL-2-YL]AMINO]PYRIDIN-4- HETNAM 3 KHQ YL]ETHYL]PIPERAZIN-1-YL]-3,3,3-TRIS(FLUORANYL)PROPAN- HETNAM 4 KHQ 1-ONE FORMUL 2 KHQ C28 H31 F3 N8 O HELIX 1 AA1 PRO A 48 LYS A 61 1 14 HELIX 2 AA2 SER A 93 GLU A 99 1 7 HELIX 3 AA3 GLU A 100 ALA A 104 5 5 HELIX 4 AA4 PRO A 108 ASN A 129 1 22 HELIX 5 AA5 LYS A 137 GLY A 139 5 3 HELIX 6 AA6 THR A 176 LEU A 180 5 5 HELIX 7 AA7 VAL A 202 GLY A 217 1 16 HELIX 8 AA8 LYS A 231 LYS A 241 1 11 HELIX 9 AA9 SER A 270 LEU A 285 1 16 HELIX 10 AB1 GLY A 294 HIS A 307 1 14 HELIX 11 AB2 THR A 331 LYS A 344 1 14 HELIX 12 AB3 LEU A 366 PHE A 370 5 5 HELIX 13 AB4 ASP A 407 VAL A 481 1 75 HELIX 14 AB5 ALA A 493 SER A 527 1 35 HELIX 15 AB6 ASP A 534 GLY A 541 1 8 HELIX 16 AB7 ARG A 547 ARG A 573 1 27 HELIX 17 AB8 ALA A 576 GLU A 604 1 29 HELIX 18 AB9 GLU A 604 GLN A 648 1 45 HELIX 19 AC1 TYR A 650 LEU A 654 5 5 SHEET 1 AA1 5 HIS A 7 GLY A 18 0 SHEET 2 AA1 5 ALA A 21 HIS A 28 -1 O ARG A 27 N LEU A 8 SHEET 3 AA1 5 LEU A 34 VAL A 39 -1 O ILE A 37 N PHE A 24 SHEET 4 AA1 5 LYS A 82 GLU A 87 -1 O MET A 86 N ALA A 36 SHEET 5 AA1 5 LEU A 70 GLU A 75 -1 N ALA A 72 O ILE A 85 SHEET 1 AA2 2 ILE A 141 ILE A 145 0 SHEET 2 AA2 2 SER A 151 LEU A 155 -1 O LYS A 154 N MET A 142 SHEET 1 AA3 3 PHE A 221 ARG A 222 0 SHEET 2 AA3 3 SER A 247 GLN A 250 1 O GLY A 248 N ARG A 222 SHEET 3 AA3 3 ILE A 257 SER A 260 -1 O ASP A 258 N VAL A 249 SHEET 1 AA4 5 THR A 320 ILE A 326 0 SHEET 2 AA4 5 MET A 309 SER A 315 -1 N ILE A 311 O ILE A 324 SHEET 3 AA4 5 ILE A 379 VAL A 382 1 O ILE A 379 N HIS A 312 SHEET 4 AA4 5 GLU A 351 TYR A 354 -1 N GLU A 351 O VAL A 382 SHEET 5 AA4 5 ARG A 357 LEU A 359 -1 O ARG A 357 N TYR A 354 SITE 1 AC1 15 SER A 12 ASP A 13 ILE A 14 LEU A 15 SITE 2 AC1 15 VAL A 23 ARG A 25 ALA A 36 MET A 86 SITE 3 AC1 15 GLU A 87 PHE A 88 CYS A 89 PRO A 90 SITE 4 AC1 15 GLY A 92 MET A 142 ASP A 157 CRYST1 136.354 136.354 87.195 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007334 0.004234 0.000000 0.00000 SCALE2 0.000000 0.008468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011469 0.00000